Efficacy of maintenance use of anticholinergic agents
Authors:
- 1 November 1993
- journal article
- clinical trial
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 88 (5) , 381-384
Abstract
Twenty‐seven long‐term psychiatric inpatients maintained on neuroleptics with concomitant antiparkinsonian medication were entered into a study in which anticholinergic medication was gradually withdrawn in a randomized double‐blind within‐subjects design. The extrapyramidal symptoms of each patient were compared when taking their usual anticholinergic medication, when taking placebo and when taking no antiparkinsonian drug. The relapse rate on no medication was 14%, and if patients relapsed on no medication they also relapsed on placebo. The relapse rate was not significantly different on active medication. Nor were there significant differences in ratings of parkinsonism or dyskinesia. The lack of difference between double‐blind and overt withdrawal does not mean that studies that find a much higher relapse rate are necessarily unaffected by nonspecific factors, as significant unblinding may occur in clinical trials.Keywords
This publication has 12 references indexed in Scilit:
- A Clinical Guide to Antipsychotic DrugsDrugs, 1992
- Comment on the WHO Consensus StatementThe British Journal of Psychiatry, 1990
- Prophylactic Use of Anticholinergics in Patients on Long-Term Neuroleptic TreatmentThe British Journal of Psychiatry, 1990
- A Rating Scale for Drug-Induced AkathisiaThe British Journal of Psychiatry, 1989
- A Study of the Need for Anticholinergic Medication in Patients Treated with Long-Term AntipsychoticsAustralian & New Zealand Journal of Psychiatry, 1986
- Dr. Manos RepliesAmerican Journal of Psychiatry, 1981
- Gradual Withdrawal of Antiparkinson Medication in Chronic Schizophrenics: Any Better Than the Abrupt?Journal of Nervous & Mental Disease, 1981
- Are Prophylactic Antiparkinson Drugs Necessary?Archives of General Psychiatry, 1978
- The Abrupt Withdrawal of Antiparkinsonian Drugs in Schizophrenic PatientsThe British Journal of Psychiatry, 1974
- Evaluating the Long-Term Need for Antiparkinson Drugs by Chronic SchizophrenicsArchives of General Psychiatry, 1972